-
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
NCT07227532 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 22 Years and older ·
Sex: All (male and female)
· Michigan: Ypsilanti
-
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
NCT06455098 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Michigan: Royal Oak
-
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
NCT07625215 ·
Phase: Phase 2 ·
Ages: 18 Years to 85 Years ·
Sex: All (male and female)
· Michigan: Detroit
-
Anthocyanin-Rich Table Grape Powder for Prophylaxis of Post-Operative Atrial Fibrillation
NCT05991700 ·
Phase: Phase 1, Phase 2 ·
Ages: 18 Years to 79 Years ·
Sex: All (male and female)
· Michigan: Ann Arbor
-
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
NCT04045665 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Ann Arbor
-
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
NCT03907046 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Ann Arbor, Detroit, Flint, Grand Rapids
-
BoxX-NoAF Clinical Trial
NCT06989775 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 65 Years and older ·
Sex: All (male and female)
· Michigan: Grand Rapids, Ypsilanti
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
NCT06959121 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 85 Years ·
Sex: All (male and female)
· Michigan: Ann Arbor
-
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
NCT06784466 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years to 80 Years ·
Sex: All (male and female)
· Michigan: Ann Arbor
-
Medtronic Terminate AF Study
NCT03546374 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Grand Rapids
-
PULSED AF Post-Approval Study
NCT06578104 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Royal Oak
-
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
NCT06957366 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Detroit
-
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)
NCT06844227 ·
Phase: Not specified ·
Ages: 18 Years to 100 Years ·
Sex: All (male and female)
· Michigan: Detroit
-
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
NCT04088071 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Detroit, Lansing, Royal Oak, Ypsilanti
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
NCT06735534 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Royal Oak
-
Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA
NCT07275151 ·
Phase: Not specified ·
Ages: 21 Years and older ·
Sex: All (male and female)
· Michigan: Ypsilanti
-
STOP AF First Post-Approval Study
NCT05227053 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Detroit
-
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
NCT07175428 ·
Phase: Phase 2 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Farmington Hills, Flint
-
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
NCT07626411 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Bloomfield Hills, Farmington Hills
-
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
NCT07430956 ·
Phase: Phase 3 ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Bloomfield Hills, Farmington Hills, Flint
-
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
NCT05712200 ·
Phase: Phase 3 ·
Ages: 65 Years and older ·
Sex: All (male and female)
· Michigan: Lansing, Petoskey, Southgate
-
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698 ·
Phase: Not applicable (e.g. observational or device study) ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Ann Arbor, Detroit
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
NCT06324201 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Lansing, Ypsilanti
-
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
NCT05836987 ·
Phase: Phase 3 ·
Ages: 22 Years to 85 Years ·
Sex: All (male and female)
· Michigan: Detroit, Grand Rapids, Royal Oak, Ypsilanti
-
Tracking Results of Ablations to Combat AF Registry Generation 2
NCT05111015 ·
Phase: Not specified ·
Ages: 18 Years and older ·
Sex: All (male and female)
· Michigan: Ann Arbor, Grand Rapids